Corporate

Hikma Pharmaceuticals Preliminary Results

Hikma Pharmaceuticals PLC (“Hikma”) (LSE: HIK) (NASDAQ Dubai:HIK), the fast growing multinational pharmaceutical group, today reports its preliminary results for the year ended 31 December 2012.